Milosz Majewski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Milosz Majewski has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Jef D. Boeke
Institute for Systems Genetics, Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, USA
2 shared publications - Ran Brosh
Institute for Systems Genetics, NYU Langone Health, New York, USA
2 shared publications André M. Ribeiro-Dos-Santos
Institute for Systems Genetics, NYU School of Medicine, New York, NY 10016, USA
1 shared publication- Brendan R. Camellato
Institute for Systems Genetics, NYU Langone Health, New York, USA
1 shared publication - Camila Coelho
Institute for Systems Genetics, NYU Langone Health , New York , NY 10016 , USA
1 shared publication Colleen McLoughlin
Institute for Systems Genetics, NYU School of Medicine, New York, NY 10016, USA
1 shared publication
Latest Publications
- Open Access
Synthetic genomic dissection of enhancer context sensitivity and synergy
Noncoding disease and trait-associated genetic variation is frequently interpreted in the context of genomic regulatory elements such as DNase I hypersensitive sites (DHSs). But while most DHSs lie within a few kilobases of another DHS, regulatory elements are typically analyzed individually without accounting for their neighbors. Based on our Big-IN technology for scarless genome engineering, we have developed a high-throughput multiplexed delivery pipeline to analyze >100 engineered payloads in hundreds of mouse embryonic stem cell (mESC) clones. We characterize multiple heterotypic DHS combinations from different critical mESC regulator loci, all delivered in a constant chromosomal context replacing the Sox2 Locus Control Region (LCR). We identify widespread examples of context-dependent enhancers which have no activity on their own but can double the activity of a neighboring DHS. We find pervasive context dependencies that depend on the specific DHS pairings. We further show that synergy between neighboring DHSs decays as a characteristic function of distance, with its influence extending up to several kilobases. We fine map this context dependency to the contribution of individual transcription factor recognition sequences. Our approach implicates the specific sequence and architectural features underpinning pervasive genomic context effects, and outlines key directions for modeling the functional impact of noncoding regulatory variation on common human traits and diseases.
Open AccessSynthetic genomic dissection of enhancer context sensitivity and synergy
Noncoding disease and trait-associated genetic variation is frequently interpreted in the context of genomic regulatory elements such as DNase I hypersensitive sites (DHSs). But while most DHSs lie within a few kilobases of another DHS, regulatory elements are typically analyzed individually without accounting for their neighbors. Based on our Big-IN technology for scarless genome engineering, we have developed a high-throughput multiplexed delivery pipeline to analyze >100 engineered payloads in hundreds of mouse embryonic stem cell (mESC) clones. We characterize multiple heterotypic DHS combinations from different critical mESC regulator loci, all delivered in a constant chromosomal context replacing the Sox2 Locus Control Region (LCR). We identify widespread examples of context-dependent enhancers which have no activity on their own but can double the activity of a neighboring DHS. We find pervasive context dependencies that depend on the specific DHS pairings. We further show that synergy between neighboring DHSs decays as a characteristic function of distance, with its influence extending up to several kilobases. We fine map this context dependency to the contribution of individual transcription factor recognition sequences. Our approach implicates the specific sequence and architectural features underpinning pervasive genomic context effects, and outlines key directions for modeling the functional impact of noncoding regulatory variation on common human traits and diseases.
- Open Access
- 16 June 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (13) , e72
CREEPY: CRISPR-mediated editing of synthetic episomes in yeast
Use of synthetic genomics to design and build ‘big’ DNA has revolutionized our ability to answer fundamental biological questions by employing a bottom-up approach. Saccharomyces cerevisiae, or budding yeast, has become the major platform to assemble large synthetic constructs thanks to its powerful homologous recombination machinery and the availability of well-established molecular biology techniques. However, introducing designer variations to episomal assemblies with high efficiency and fidelity remains challenging. Here we describe CRISPR Engineering of EPisomes in Yeast, or CREEPY, a method for rapid engineering of large synthetic episomal DNA constructs. We demonstrate that CRISPR editing of circular episomes presents unique challenges compared to modifying native yeast chromosomes. We optimize CREEPY for efficient and precise multiplex editing of >100 kb yeast episomes, providing an expanded toolkit for synthetic genomics.
- 16 June 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (13) , e72
Open AccessCREEPY: CRISPR-mediated editing of synthetic episomes in yeast
Use of synthetic genomics to design and build ‘big’ DNA has revolutionized our ability to answer fundamental biological questions by employing a bottom-up approach. Saccharomyces cerevisiae, or budding yeast, has become the major platform to assemble large synthetic constructs thanks to its powerful homologous recombination machinery and the availability of well-established molecular biology techniques. However, introducing designer variations to episomal assemblies with high efficiency and fidelity remains challenging. Here we describe CRISPR Engineering of EPisomes in Yeast, or CREEPY, a method for rapid engineering of large synthetic episomal DNA constructs. We demonstrate that CRISPR editing of circular episomes presents unique challenges compared to modifying native yeast chromosomes. We optimize CREEPY for efficient and precise multiplex editing of >100 kb yeast episomes, providing an expanded toolkit for synthetic genomics.